Assessing Severity. Management of Stable COPD. General Approach. Short Acting Bronchodilators. Staging System (GOLD)

Similar documents
Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

A Visual Approach to Simplifying Respiratory Drug Regimens

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Prescribing guidelines: Management of COPD in Primary Care

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

Improving Outcomes in COPD

Presented by UIC College of Nursing

Chronic Obstructive Pulmonary Disease 1/18/2018

VA/DoD Clinical Practice Guideline Management of COPD Pocket Guide

Provider Respiratory Inservice

Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center

COPD Update. Plus New and Improved Products for Inhaled Therapy. Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor

Exacerbations of COPD. Dr J Cullen

COPD: Current Medical Therapy

Foundations of Pharmacology

UPMC HEALTH PLAN COPD CLINICAL PRACTICE GUIDELINE

Chronic Obstructive Pulmonary Disease

Balanced information for better care. Helping patients with COPD breathe easier

COPD. Breathing Made Easier

COPD. Stan Kellar, MD. Physiology 11/4/2014. Chief of Clinical Affairs, BH NLR Pulmonary Medicine Sleep Medicine

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

Women Beware-The Threat of COPD

Salford COPD Treatment Pathway

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES

COPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

If you require this document in another format such as Braille, large print, audio or another language please contact the Trusts Communications Team

COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.

COPD. Helen Suen & Lexi Smith

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

COPD/Asthma. Prudence Twigg, AGNP

What is COPD? COPD Pharmacotherapy. COPD Mortality Is Increasing

Inhalation devices, proper technique and cleaning

COPD: A Renewed Focus. Disclosures

Incorporating Newer Therapies and Strategies to Improve COPD Outcomes: A Practical Guide for Pharmacists. Learning Objectives.

PATIENT INFORMATION Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet

Algorithm for the use of inhaled therapies in COPD Version 2 May 2017

Nancy Davis, RRT, AE-C

See Important Reminder at the end of this policy for important regulatory and legal information.

Women Beware The Threat of COPD

COPD. Definitionn. make. when (bronchioles) in. the lungs. Wheezing Chest tightness. your lungs. greenish. Lack of energy

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 15 December 2010

Chronic obstructive pulmonary disease

Common Inhaled Asthma Medications Dose Comparison and Tips for Use

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

AECOPD: Management and Prevention

COPD. Understanding. An educational health series from National Jewish Health IN THIS ISSUE. What is COPD? 2. How is COPD Managed?

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

Medications Affecting The Respiratory System

Disclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:

Fighting for Air, In Emphysema

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

Drug Class Monograph

Respiratory Health. Asthma and COPD

Algorithm for the use of inhaled therapies in COPD

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 25 May 2011

Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More

COPD: GOLD guidelines Ijlal Babar, MD Medical Director Pulmonary CCM, Pulmonary Hypertension Center SRHS

COPD Robert Schilz DO, PhD Pulmonary, Critical Care and Sleep Medicine University Hospitals Case Medical Center

Diagnosis and Management of Asthma

Wirral COPD Prescribing Guidelines

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

COPD. Diseases and Conditions

Chronic Obstructive Pulmonary Disease (COPD)

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

Integrated Cardiopulmonary Pharmacology Third Edition

Debating the use of inhaled corticosteroids in the treatment of COPD. COPD Epidemiology. A quick patient case. Risk Factors for COPD 1,2

Asthma COPD Update 2018

Address Comorbidities

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

MDI Bonanza. Dwayne Griffin, DO

Treatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1

History & Development

PFT s / 2017 Pulmonary Update. Eric S. Papierniak, DO University of Florida NF/SG VHA

NHS Dumfries & Galloway Triple therapy in COPD patients over 16 years

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Better Living with Obstructive Pulmonary Disease A Patient Guide

Chronic Obstructive Pulmonary Disease Guidelines and updates

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant

COPD in primary care: reminder and update

How can I benefit most from my COPD medications?

Proposed Preferred Drug List. Clinical Criteria

Asthma. Definition. Symptoms

aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A.

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

Improving Outcomes in COPD. Improving Outcomes in COPD 4/4/2018

Update on Pulmonary Diseases. Jeffrey Lessar, MD

Medicines Management of Chronic Obstructive Pulmonary Disease (COPD)

COPD exacerbation. Chiara Maruggi, PGY2

Transcription:

William P. Saliski Jr. DO Montgomery Pulmonary Consultants Management of Stable COPD Pharmacotherapy Oxygen Smoking Cessation Vaccinations Rehabilitation Surgery Future Discussions Assessing Severity Staging System (GOLD) Defines disease severity by FEV1 and ratio FEV1/FVC Used as a guide to manage patient therapy General Approach Pharmacotherapy prevent/decrease symptoms reduce exacerbations improve health status improve exercise capacity Short Acting Bronchodilators Beta agonists albuterol, levabuteral, pirbuterol (SABA) Anticholinergics ipratropium bromide

Short Acting Bronchodilators Names Albuterol Sulfate Levalbuterol Porbuterol Provental HFA Ventolin HFA Proair HFA Xopenex Maxair Ipatroprium Bromide Atrovent Beta Agonist Therapy Dosing : 2 Puffs as needed Side Effects : tremor, reflex tachycardia hypokalemia ( extreme use ) Combu Med Combivent Anticholinergic Therapy Dosing 2 puffs 4x/daily 18 meq/puff 200 puffs/canister Side Effects dry mouth, constipation? Cardiovascular side effects Combination Therapy (Combivent) Dosing 2 puffs 4x/daily Combination therapy increased FEV1 more than either agent alone Long Acting Bronchodilators (LABA) Salmeterol Serevent Formoterol Foradil Arfomoterol Brovena (nebulizer use) Tiotropium Spiriva Therapy in Gold II IV Beta Agonists (LABA) Dosing both are dry powder used 2x/daily Side Effects same as short acting agents increase risk of death (Smart trial)

Dosing dry powder 1x/daily Anticholinergics (Long Acting) Comparison Shopping Foradil> Serevent Spiriva>Foradil>Serevent Side Effects dry mouth, headache constipation, glaucoma (worsening) Foradil has rapid onset, lasts longer Spiriva affords better bronchodilation and better side effect profile Bronchodilators Plus Inhaled Glucocorticosteroids (ICS) COPD characterized by airway and systemic inflammation Numerous ICS on the market No real difference in products ICS should not be used as sole therapy Bronchodilator Plus ICS Advair Discus/Advair HFA (Fluticasone/Salmeterol)250 meq/50 mcg 2x/daily Symbicort 160/4.5 (Budesonide/Formeterol)2 puffs 2x/daily Side Effects (ICS) oral candidiasis, pneumonia, adrenal suppression

Triple Inhaler Therapy Stage III IV Gold LABA/ICS and tiotroprium bromide Decrease mortality, exacerbations, and hospitalizations Theophylline Mechanism of action controversial Offers moderate bronchodilation Long acting extended release preps Narrow LD 50 Metabolized in liver Keep serum level 8 to 12 mcg/ml Rarely Used Medications Systemic Glucocorticoids Mucoactive Agents Chronic Antibiotic Therapy Supplemental Therapy Oxygen Secretion Clearance Smoking Cessation Vaccinations Rehabilitation Nutrition Oxygen Therapy Long term oxygen therapy (LTOT) increases survival and improves quality of life Minimal adverse effects (humidify!) Close government regulation 2 billion dollars per year (Medicare)

LTOT Indications PaO2 55 mm Hg or SaO2 88 % Cor Pulmonale PaO2 59 mm Hg/SaO2 89 % (Hct > 55 %, EKG p pulmonale, CHF Desaturation with above numbers w/ exercise or at sleep Prescribing Oxygen Obtain baseline ABG (does O2 Sat correlate?) (is patient hypercarbic?) Keep PaO2 60 to 65 mm Hg Keep SaO2 92% Usually order 2L NC (continuous, exercise, sleep?) Equipment Selection Keep your patient mobile Select lightest, most portable Think liquid O2 Oxygen conserving device Secretion Clearance Postural drainage Flutter valve therapy Hydration? Oxygen concentrator (bedroom) Vaccinations Pneumococcal/polysaccharide vaccine COPD 65 yrs old COPD 65 yrs old w/ FEV1< 40% predicted Active tobacco use Give initial vaccine and 5 year booster Does not reduce mortality Vaccinations Influenza vaccination given to all patients with COPD Decrease risk of influenza significantly DOES NOT CAUSE THE FLU! Timing?

Clinician advice Smoking Cessation Nicotine replacement therapy Buproprion (Zyban) 150 mg Varenicline (Chantix) 1 mg Combination therapy best outcome Rehabilitation Low cost effective program Optimizes physical and social functioning Reduces hospitalization, LOS,? Mortality Medically supervised Rehabilitation Baptist Medical Center South Anita Jones 334.286.2859 Covered by Major Medical Insurances Nutrition 30% of patients with severe COPD are protein calorie malnourished Increase mortality, decrease muscle function, decrease immunity Try high caloric dietary supplements Magestrol acetate (Megace)